Literature DB >> 19262901

Carcinoma of unknown primary origin.

Gauri R Varadhachary1.   

Abstract

Carcinoma of unknown primary origin (CUP) is a heterogeneous group of cancers defined by the presence of metastatic disease with no identified primary tumor at presentation. Identifying patients with prognostically favorable disease is important, since they may derive substantial benefit, including prolonged survival, from directed treatment. In CUP cases, a focused search for the primary tumor is recommended. Whether CUP is a distinct molecular genotype-phenotype relative to metastases of known cancers is unknown. However, use of a robust immunohistochemical panel and emerging molecular data may permit development of a tailored treatment algorithm for CUP patients that will include appropriate use of targeted agents.

Entities:  

Year:  2007        PMID: 19262901      PMCID: PMC2631214     

Source DB:  PubMed          Journal:  Gastrointest Cancer Res        ISSN: 1934-7820


  52 in total

1.  Identification from public data of molecular markers of adenocarcinoma characteristic of the site of origin.

Authors:  Jayne L Dennis; J Keith Vass; Ernst C Wit; W Nicol Keith; Karin A Oien
Journal:  Cancer Res       Date:  2002-11-01       Impact factor: 12.701

2.  Chemotherapy for patients with two favourable subsets of unknown primary carcinoma: active, but how effective?

Authors:  George Pentheroudakis; Evangelos Briasoulis; Vassilis Karavassilis; George Fountzilas; Nikolaos Xeros; George Samelis; Epaminondas Samantas; Nicholas Pavlidis
Journal:  Acta Oncol       Date:  2005       Impact factor: 4.089

3.  Unknown primary tumors: detection with dual-modality PET/CT--initial experience.

Authors:  Andreas Gutzeit; Gerald Antoch; Hilmar Kühl; Thomas Egelhof; Markus Fischer; Elke Hauth; Susanne Goehde; Andreas Bockisch; Jörg Debatin; Lutz Freudenberg
Journal:  Radiology       Date:  2004-11-24       Impact factor: 11.105

4.  One-hour paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of carcinoma of unknown primary site.

Authors:  F A Greco; J D Hainsworth
Journal:  Semin Oncol       Date:  1997-12       Impact factor: 4.929

5.  Molecular classification of human carcinomas by use of gene expression signatures.

Authors:  A I Su; J B Welsh; L M Sapinoso; S G Kern; P Dimitrov; H Lapp; P G Schultz; S M Powell; C A Moskaluk; H F Frierson; G M Hampton
Journal:  Cancer Res       Date:  2001-10-15       Impact factor: 12.701

6.  Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities.

Authors:  Gerreke Regelink; Jolijn Brouwer; Remco de Bree; Jan Pruim; Bernard F A M van der Laan; Willem Vaalburg; Otto S Hoekstra; Emile F I Comans; Arjan Vissink; C René Leemans; Jan L N Roodenburg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-05-04       Impact factor: 9.236

7.  Evaluation of six tumor markers in patients with carcinoma of unknown primary.

Authors:  N Pavlidis; J Kalef-Ezra; E Briassoulis; D Skarlos; P Kosmidis; K Saferiadis; E Bairaktari; D Bafaloukos; A Maravegias; D Theoharis
Journal:  Med Pediatr Oncol       Date:  1994

8.  Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin.

Authors:  J L Abbruzzese; M C Abbruzzese; R Lenzi; K R Hess; M N Raber
Journal:  J Clin Oncol       Date:  1995-08       Impact factor: 44.544

9.  Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies.

Authors:  A S Abutaily; B J Addis; W R Roche
Journal:  J Clin Pathol       Date:  2002-09       Impact factor: 3.411

10.  Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas.

Authors:  Douglas C Parker; Andrew L Folpe; Julie Bell; Esther Oliva; Robert H Young; Cynthia Cohen; Mahul B Amin
Journal:  Am J Surg Pathol       Date:  2003-01       Impact factor: 6.394

View more
  18 in total

Review 1.  Carcinoma of unknown primary with hepatic metastases: a need of judicious and contemplative diagnostic algorithm.

Authors:  Vikram Sai Shivaji; Joseph Charles Wilson; Noemi L Schmidt; Orpheus Kolokythas; Neeraj Lalwani
Journal:  Abdom Radiol (NY)       Date:  2020-07-06

2.  Defective DNA Mismatch Repair Influences Expression of Endometrial Carcinoma Biomarkers.

Authors:  Ekene I Okoye; Amanda S Bruegl; Bryan Fellman; Rajyalakshmi Luthra; Russell R Broaddus
Journal:  Int J Gynecol Pathol       Date:  2016-01       Impact factor: 2.762

3.  Management of neck metastases of unknown primary origin united in two European centers.

Authors:  Jos Straetmans; Julia Vent; Martin Lacko; Ernst-Jan Speel; Christian Huebbers; Robert Semrau; Frank Hoebers; Zlatan Mujagic; Jens-Peter Klussmann; Simon F Preuss; Bernd Kremer
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-11       Impact factor: 2.503

4.  Extensive diagnostic work-up for patients with carcinoma of unknown primary.

Authors:  L Meijer; R H A Verhoeven; I H J T de Hingh; A J van de Wouw; H W M van Laarhoven; V E P P Lemmens; C Loef
Journal:  Clin Exp Metastasis       Date:  2021-01-30       Impact factor: 5.150

5.  Can we infer tumor presence of single cell transcriptomes and their tumor of origin from bulk transcriptomes by machine learning?

Authors:  Hua-Ping Liu; Dongwen Wang; Hung-Ming Lai
Journal:  Comput Struct Biotechnol J       Date:  2022-05-23       Impact factor: 6.155

6.  The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody.

Authors:  Reyhan Bayrak; Hacer Haltas; Sibel Yenidunya
Journal:  Diagn Pathol       Date:  2012-01-23       Impact factor: 2.644

Review 7.  Metastasis-Initiating Cells and Ecosystems.

Authors:  Joan Massagué; Karuna Ganesh
Journal:  Cancer Discov       Date:  2021-04       Impact factor: 38.272

8.  Yield of esophagogastroduodenoscopy and colonoscopy in cancer of unknown primary.

Authors:  Muhammad Tayyab Usmani; Abdullah Bin Khalid; Syed Hasnain Ali Shah; Tauseef Ahmad; Saeed S Hamid; Syed M Wasim Jafri
Journal:  Pak J Med Sci       Date:  2013-04       Impact factor: 1.088

9.  Prognostic parameters and spinal metastases: a research study.

Authors:  Jefferson W Daniel; José C E Veiga
Journal:  PLoS One       Date:  2014-10-13       Impact factor: 3.240

10.  Pericardial effusion in a dog concurrent with carcinoma of unknown primary origin.

Authors:  M H Kang; J H Sur; H M Park
Journal:  Iran J Vet Res       Date:  2019       Impact factor: 1.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.